Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Study shows feasibility of using a robot to treat brain aneurysms

Using a robot to treat brain aneurysms is feasible and could allow for improved precision when placing stents, coils and other devices, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

23 Feb 2020

Antifibrinolytic agent could be a treatment for bleeding stroke

A common medication that reduces bleeding could be a treatment for bleeding stroke, particularly if administered quickly, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

23 Feb 2020

Secondary analysis reinforces safety of blood thinner

Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalization compared with warfarin, regardless of history of prior stroke or blood clot, according to a secondary analysis presented as late breaking science today at the American Stroke Association's International Stroke Conference 2020.

23 Feb 2020

Skipping clot-busters and using mechanical clot removal alone may be sufficient stroke treatment

Skipping IV clot-busters and using mechanical clot removal alone for strokes may be just as good as the combination of both treatments, with less risk of brain bleeding, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

23 Feb 2020

Antiplatelet medication used to treat leg pain may prevent re-blockage of carotid artery stents

Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2020. The conference, Feb. 19-21 in Los Angeles, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.

23 Feb 2020

People with higher obsessive-compulsive symptoms tend to distrust past experience

Obsessive–compulsive disorder is characterized by intrusive thoughts, urges, or images that cause marked distress, and repetitive behavioral or mental rituals.

From PLOS ONE 21 Feb 2020

New drug offers hope for preserving brain cells for a time after stroke

After 50 years of research and the testing of over 1,000 drugs, there is new hope for preserving brain cells for a time after stroke.

21 Feb 2020

Faster stroke treatment in specialized ambulances reduces patients' disability

Treating stroke patients in specialized ambulances speeds treatment and reduces patients' disability, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

21 Feb 2020

New Endothelial Cell Atlas can be used to improve treatments for many diseases

New surprising knowledge on endothelial cells in a dozen different murine tissues is now available in an open access, user-friendly, database for professionals.

20 Feb 2020

Study finds racial, ethnic disparities in stroke prevention among patients undergoing dialysis

In a study of patients with kidney failure and atrial fibrillation, racial/ethnic minorities experienced higher rates of stroke compared with non-Hispanic White patients, and they were less likely to fill prescriptions of stroke-preventive medications.

20 Feb 2020

Lower dose of clot-busting agent may reduce the need for mechanical clot removal in stroke patients

New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

Wearable magnetic brain stimulation device could improve motor function in stroke patients

A non-invasive, wearable, magnetic brain stimulation device could improve motor function in stroke patients, according to preliminary late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

New breakthrough offers hope for potential treatment of rare childhood epilepsy

Seizure disorders in babies are frightening and heartbreaking. A new basic science breakthrough offers hope for a potential treatment for rare developmental and epileptic encephalopathies resulting from a single genetic mutation.

20 Feb 2020

FETO therapy produces favorable outcomes when fetal and maternal care are highly coordinated

Researchers from The Johns Hopkins Center for Fetal Therapy report new evidence that fetuses with severe congenital diaphragmatic hernia, a rare but life-threatening, lung-damaging condition, experience a significantly high rate of success for the fetal treatment known as FETO, if they and their mothers receive coordinated and highly experienced care in the same expert setting.

20 Feb 2020

Time of day influences brain’s global signal fluctuation

As the day progresses, the strength of the brain’s global signal fluctuation shows an unexpected decrease, according to a study published on February 18 in the open-access journal PLOS Biology by Csaba Orban and a multi-disciplinary team of scientists from the Faculty of Engineering, Yong Loo Lin School of Medicine and N.1 Institute of Health at the National University of Singapore.

From PLOS ONE 19 Feb 2020

UTHealth physician-scientist receives AHA’s $1 million Merit Award for stroke research

Louise D. McCullough, MD, PhD, a physician-scientist at The University of Texas Health Science Center at Houston is a recipient of the American Heart Association's prestigious $1 million Merit Award to investigate whether the maternal microbiome influences stroke risk in offspring.

19 Feb 2020

Exploring how brain inflammation after stroke can be shaped to support recovery

University of Kentucky College of Medicine researcher Ann Stowe describes her career path as nontraditional. After earning a bachelor's degree in fine arts, Stowe decided to pursue graduate study in biomedical research instead of art history.

19 Feb 2020

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

Drugs targeting T cells may be effective in treating cerebral malaria

Researchers at the National Institutes of Health found evidence that specific immune cells may play a key role in the devastating effects of cerebral malaria, a severe form of malaria that mainly affects young children.

18 Feb 2020

Stroke News and Research

Further Reading

Study shows feasibility of using a robot to treat brain aneurysms

Antifibrinolytic agent could be a treatment for bleeding stroke

Secondary analysis reinforces safety of blood thinner

Skipping clot-busters and using mechanical clot removal alone may be sufficient stroke treatment

Antiplatelet medication used to treat leg pain may prevent re-blockage of carotid artery stents

People with higher obsessive-compulsive symptoms tend to distrust past experience

New drug offers hope for preserving brain cells for a time after stroke

Faster stroke treatment in specialized ambulances reduces patients' disability

New Endothelial Cell Atlas can be used to improve treatments for many diseases

Study finds racial, ethnic disparities in stroke prevention among patients undergoing dialysis

Lower dose of clot-busting agent may reduce the need for mechanical clot removal in stroke patients

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

Wearable magnetic brain stimulation device could improve motor function in stroke patients

New breakthrough offers hope for potential treatment of rare childhood epilepsy

FETO therapy produces favorable outcomes when fetal and maternal care are highly coordinated

Time of day influences brain’s global signal fluctuation

UTHealth physician-scientist receives AHA’s $1 million Merit Award for stroke research

Exploring how brain inflammation after stroke can be shaped to support recovery

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Drugs targeting T cells may be effective in treating cerebral malaria

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News